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DISP3 (PTCHD2), a sterol-sensing domain-containing protein, is highly expressed in neural tissue
but its role in neural differentiation is unknown. In the present study we used a multipotent
cerebellar progenitor cell line, C17.2, to investigate the impact of DISP3 on the proliferation and
differentiation of neural precursors. We found that ectopically expressed DISP3 promotes cell
proliferation and alters expression of genes that are involved in tumorigenesis. Finally, the differen-
tiation proﬁle of DISP3-expressing cells was altered, as evidenced by delayed expression of neural
speciﬁc markers and a reduced capacity to undergo neural differentiation.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction One of the genes identiﬁed in this study was Disp3 [3]. Interest-The Dispatched 3 gene (Disp3), also known as Ptchd2 and
KIAA1337, was ﬁrst reported in a human cDNA sequencing project
that was focused on identifying genes encoding large proteins in
the human brain [1].
Subsequent cloning and characterization of Disp3 revealed that
it encodes a 13-transmembrane domain-containing protein that is
related to the Dispatched family of proteins. Further, its expression
is regulated both in vivo and in vitro by thyroid hormone [2]. In
adult neural tissue, Disp3 is expressed predominantly in the hippo-
campus and cerebellum, with scattered expression in the cortex. In
ﬁbroblasts, ectopic expression of DISP3 leads to increased cellular
cholesterol levels that exhibit an altered distribution pattern.
Based on these ﬁndings it was proposed that DISP3 might
represent a new molecular link between thyroid hormone and
cholesterol metabolism [2].
Previous studies in mice have demonstrated that retroviral
insertional mutagenesis induced by a recombinant M-MLV
encoding PDGF-B results in a high incidence of glioblastomas.ingly, a subsequent study further demonstrated a link between
Disp3 and oncogenesis, showing that Disp3 expression was ampli-
ﬁed in long latency tumors [4].
To identify the pattern and level of Disp3 expression in human
brain cancer we investigated datasets from the publicly available
Oncomine database (www.oncomine.org) [5]. Analysis of the
Northcott 3 [6], Kool et al. [7] and Fattet et al. [8] brain datasets
revealed that Disp3 mRNA was signiﬁcantly elevated in human
medulloblastoma.
Medulloblastoma, the most common cause of oncological death
in children, accounts for over 20% of all central nervous system
tumors. According to the WHO classiﬁcation, medulloblastoma is
deﬁned as a grade IV malignant embryonal neoplasm that arises
from the cerebellum with ﬁve histological varieties [9]. Several
research groups have performed gene-expressing proﬁling of
medulloblastoma and have identiﬁed four molecular subtypes:
WNT, Sonic Hedgehog (SHH), Group 3, and Group 4. These molec-
ular subtypes exhibit distinct gene expression, mutational proﬁles,
and prognosis and indicate that medulloblastoma is not just one
disease (reviewed in [10]).
Given that Disp3 expression is elevated in medulloblastoma, we
wished to investigate what role this gene may play in neural pro-
genitor commitment and differentiation. To this end we used the
multipotent neural progenitor cell line C17.2 originally established
from cerebellar neural cells isolated from the external germinal
layer (EGL) of neonatal mice that were subsequently immortalized
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potential to differentiate into neurons or glia depending on
micro-environmental signals, and can thus be used as an alterna-
tive to primary brain tissue culture [12].
2. Materials and methods
2.1. Cell cultures and reagents
C17.2 cells, a generous gift from Dietmar Spengler (Max-Planck
Institute of Psychiatry, Munich, Germany), were grown in DMEM
(Sigma) supplemented with 10% FCS, 5% horse serum, 2 mM L-glu-
tamine, 100 U penicillin/ml and 100 lg streptomycin/ml (Gibco).
The cells were passaged every 3rd day using 0.05% trypsin/EDTA
and reseeded at a density of 1  104/cm2. For differentiation exper-
iments cells were seeded at a density of 0.26  103/cm2 in standard
growth medium. One day later the cells were washed and incu-
bated in differentiation medium DMEM:F12 (Sigma) containing
N2 supplements (Gibco), NGF and BDNF (10 ng/ml of each neuro-
trophic factor, R&D Systems).
The human DAOY cell line was obtained from Mathias
Heikenwaelder (Institute of Virology, TU Munich, Germany) and
cultured in IMEM (Gibco) with 10% FBS and 100 U penicillin/ml
and 100 lg streptomycin/ml.
2.2. Viral production, transduction of C17.2 cells and transfection
of DAOY cells
To generate Disp3-expressing C17.2 cells, the full-length human
Disp3 was cloned into the retroviral vector pBABE-Hygro. Retrovi-
ruses were prepared by transfecting the expression vector into
Phoenix cells using Lipofectamine reagent (Invitrogen). Viral
supernatant was harvested at 48 and 72 h post transfection.
C17.2 cells were incubated with virus supernatant and polybrene
(4 lg/ml) for 6 h before adding the fresh medium and hygromycin
was added 48 h later. To generate Disp3-expressing DAOY cells, the
full-length human Disp3 was cloned into the pCDNA3 vector.
DAOY cells were transfected using Lipofectamine and neomycin
was added two days after transfection. The control cells were gen-
erating by transducing C17.2 and DAOY cells by empty vectors
pBABE-Hygro and pCDNA3, respectively.
2.3. RT-PCR and real-time qPCR
Total RNA was isolated using PureLink RNA Mini Kit (Ambion)
according to the manufacturer’s protocol. For RT-PCR, 2 lg of total
RNA was reverse transcribed using random hexamer primers
(Invitrogen) and M-MLV Reverse Transcriptase (Promega). All qPCR
reactions were performed in triplicate using the SYBR Green I
Master mix and the LightCycler 480 system (Roche).
2.4. Microarray analysis
The quality and concentration of RNA were measured and RNA
integrity was analyzed using Agilent Bioanalyzer 2100 (Agilent).
Microarray analysis was conducted using Illumina MouseRef-8 v2
Expression BeadChips according to their standard protocol. The
analysis was performed in four biological replicates per group.
The raw data were preprocessed using GenomeStudio software
and analyzed within the limma package [13] of Bioconductor
[14] as described elsewhere [15]. A moderated t-test was used to
detect transcripts differentially expressed between the treated
samples and controls. As the analysis was considered exploratory,
we used weak criteria to select differentially transcribed
genes (P < 0.05, which corresponds to Storey’s q < 0.9 [16], and
|log2FC| > 0.6). The microarray data were deposited in the
ArrayExpress database under accession number E-MTAB-2975.2.5. Primers
The following primer sequences were used: gapdh 50-CCATGAC
AACTTTGGCATTG-30 and 50-TCCCCACAGCCTTAGCAG-30, ubb 50-AT
GTGAAGGCCAAGATCCAG-30 and 50-TAATAGCCACCCCTCAGACG-30,
disp3 50-CAGCAGCTTTGACCTCTTCA-30 and 50-GCAACATCTGCAG-
GAAGGA-30, bIII-tubulin 50-TGGACAGTGTTCGGTCTGG-30 and 50-C
CCTCCGTATAGTGCCCTTTG-30, gfap 50-TGAGGCAGAAGCTCCAAGA-
30 and 50-CCAGGGTGGCTTCATCTGC-30, nestin 50-AGGCTGAGAACTC
TCGCTTGC-30 and 50-GGTGCTGGTCCTCTGGTATCC-30, epb4.1l3 50-
GCCCAGCTATCAGAAGATATCAC-30 and 50-AGCTCTGACTGCACCGTG
TAGGA-30, prelp 50-GAACTTCTAGCTGGCTCTCT-30 and 50-GGATGCC
CTCATGATCCAGG-30.
2.6. Proliferation assay
Cell proliferation was measured using a thymidine incorpora-
tion assay. Cells were plated at a density of 3  103 cells/well in
96-well plates. After 12 h, cells were pulsed with [methyl-3H]
thymidine (UJV Rez) and cultured for an additional 6 h. Cells were
harvested onto Filtermat using a FilterMate Harvester. Incorpo-
rated radioactivity was quantiﬁed using MicroBeta2 Microplate
scintillation counter (PerkinElmer).
2.7. Expression of recombinant DISP3 protein and production
of antibody
The expression vector encoding amino acids 692–1115 of DISP3
(NP_001186105.1) was transformed into BL21(DE3) Escherichia coli
cells. The recombinant His-DISP3 protein was expressed, puriﬁed
and used to immunize New Zealand rabbits as described earlier
[2]. Immune sera were collected three weeks after the ﬁnal immu-
nization and puriﬁed using a Melon gel puriﬁcation kit (Thermo
Scientiﬁc).
2.8. Immunoblotting and immunoﬂuorescence
Protein samples were separated by SDS–PAGE using 4–15% pre-
cast gradient polyacrylamide gels (Biorad). Proteins were trans-
ferred onto nitrocellulose membranes, which were subsequently
blocked in a solution containing 5% non-fat milk dissolved in TBS
and 0.05% Tween-20 (TBST). Filters were incubated in primary
antibody diluted in 1% milk/TBST overnight before being washed
and incubated with secondary antibody (ECL kit, GE Life Sciences).
For the detection of proteins via immunoﬂuorescence, cells
were grown on glass coverslips, ﬁxed in 3% paraformaldehyde
and permeabilized with 0.2% Triton X-100 before incubation with
primary antibodies: polyclonal anti-DISP3 antibody (see above)
or mouse anti-nestin (1:400, Millipore), mouse anti-bIII tubulin
(1:1000, R&D systems), mouse anti-GFAP (1:400, Sigma), mouse
anti-GAPDH (1:2000, GeneTex). Staining was visualized by the bio-
tin-streptavidin method using streptavidin conjugated to Alexa
Fluor 555 (Invitrogen).
2.9. Neutral lipid staining
Neutral lipid staining was carried out in ﬁxed C17.2 cells using
Nile Red (ﬁnal concentration 1 lg/ml) and analyzed using the
Operetta High-Content Imaging System (PerkinElmer). Results
were evaluated using Columbus software (PerkinElmer).
3. Results
3.1. Ectopic expression of DISP3 in C17.2 neural stem cells
C17.2 cells overexpressing DISP3 were generated by retroviral
transduction. To conﬁrm increased Disp3 expression, RT-PCR was
Fig. 2. Ectopically expressed DISP3 promotes cell proliferation in neural cells. Cell
proliferation of control and DISP3 cells was measured by a thymidine incorporation
assay in C17.2 (A) and DAOY (B) cell lines. Bars represent the average of at least
three independent experiments, with error bars representing standard deviation
and the level of statistical signiﬁcance (⁄⁄⁄P < 0.001). Control (empty vector).
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(Fig. 1A). DISP3 protein levels were examined using a rabbit poly-
clonal antibody generated against a highly conserved C-terminal
region of DISP3. As a control, a previously utilized DISP3 antibody
generated against the N-terminal region was also used [2].
Immunoblotting of protein extracts from both control and DISP3-
expressing cells showed a signiﬁcant increase in the level of a pro-
tein of approximately 150 kDa in DISP3-expressing cells (Fig. 1B).
The same staining pattern was obtained using the antibody against
the DISP3 N-terminal region (data not shown). Immunoﬂuores-
cence staining of ﬁxed cells similarly demonstrated an increase
in the expression of DISP3 in overexpressing cells and its localiza-
tion predominantly restricted to the cytoplasm (Fig. 1C).
3.2. DISP3 overexpression promotes proliferation of neural cells
During routine cultivation of C17.2 cells we observed that cells
ectopically expressing DISP3 seemed to proliferate faster than
control cells. To quantitate cell proliferation, a thymidine incorpo-
ration assay was performed. The proliferation rate of C17.2 cells
ectopically expressing DISP3 was increased approximately 1.7-fold
compared to control cells (Fig. 2A). Furthermore, when a human
medulloblastoma cell line (DAOY) that normally expresses very
low levels of endogenous DISP3 was transfected with a Disp3
expression vector, its proliferation rate increased even further
(1.9-fold, Fig. 2B). Taken together, these results suggest that DISP3
overexpression may provide a growth advantage by increasing cell
proliferation.
3.3. DISP3 overexpression leads to altered gene expression in C17.2
cells
Microarray analysis was used to identify genes whose expres-
sion was altered by the ectopic expression of DISP3. Total RNAs
from control and DISP3 C17.2 cell lines were isolated and hybrid-
ized to the Illumina Mouse Expression Chips. Comparison of the
resultant expression proﬁles established a list of genes whose
expression was signiﬁcantly modiﬁed by increased DISP3 expres-
sion (Fig. 3A). QPCR was used to conﬁrm the reduction in mRNAFig. 1. C17.2 cells ectopically express DISP3. C17.2 cells were infected with a
retrovirus encoding human DISP3 and empty retroviral vector (control). Expression
was conﬁrmed by RT-PCR (A), western blot (B) and immunoﬂuorescence (C). Gapdh
served as a loading control (A,B). Cells were stained with a polyclonal DISP3
antibody (red), and DAPI (blue) was used to stain nuclei (C).expression of erythrocyte protein band 4.1-like 3 (Epb4.1l3, 4.1B)
and proline arginine-rich and leucine-rich repeat protein (Prelp).
Compared to control cells, the relative expression of Epb4.1l3
and Prelp in C17.2 DISP3 cells was decreased by 27% and 45%,
respectively (Fig. 3B). In situ hybridization data obtained from
the Allen Brain Atlas demonstrate that both genes are expressed
within the mouse brain (Fig. 3C, http://www.brain-map.org). Spe-
ciﬁcally, Epb4.1l3 exhibits prominent expression in the hippocam-
pus, olfactory bulb and Purkinje cells of the cerebellum. Prelp is
expressed similarly, albeit at much lower levels. Interestingly,
Epb4.1l3 is frequently lost in a variety of human tumors including
meningioma and is thought to act as a negative regulator of tumor
progression [17]. Prelp is a member of the small leucine-rich
proteoglycan family that is involved in the biology of meningioma
and was found to be differentially expressed in glioblastoma mul-
tiforme and meningioma brain tumors [18].
3.4. Disp3 overexpression affects the differentiation of neural cells
Neural progenitor C17.2 cells have the capacity to differentiate
into neurons or glial cells and when cultured in the standard
growth medium show typical morphology of undifferentiated cells.
Cells cultured under differentiation conditions change their
morphology with a fraction of cells generating dense cell bodies
– prospective neurons and astrocytes (Fig. 4A) growing on top of
the progenitor cells.
In undifferentiated C17.2 cells the type-IV intermediate ﬁla-
ment nestin, which is used to characterize progenitor cells [19],
was detected by qPCR and immunoﬂuorescence staining in both
control and DISP3-expressing cells. Upon neural differentiation
into both cell types, nestin mRNA levels signiﬁcantly decreased
over time. Compared to control cells, nestin expression levels were
only higher in DISP3-expressing cells during the initial phases of
differentiation with no difference seen after day 3 (Fig. 4B line
graph, day 0 of differentiation is highlighted in the bar graph).
Whilst nestin mRNA differences between control and DISP3 cells
were not statistically signiﬁcant, there was an obvious difference
detected at the protein level. Compared to day 0, control cells
showed a signiﬁcant decrease in nestin staining by day 2, which
was not observed in DISP3-expressing cells (Fig. 4B).
To identify neurons during neuronal differentiation, we
analyzed bIII-tubulin (part of the microtubular complex, [20])
Fig. 3. DISP3 expression alters gene expression in C17.2 cells. (A) List of genes with
altered gene expression in DISP3-overexpressing cells over control cells obtained by
microarray expression proﬁling. (B). Relative expression of Epb4.l3 and Prelp in
control and DISP3 cells was conﬁrmed by quantitative RT-PCR. Results are an
average of at least three independent experiments with error bars representing
standard deviation (⁄⁄P < 0.01, ⁄⁄⁄P < 0.001). Control (empty vector). (C) Represen-
tative sagittal section of an adult mouse brain hybridized with antisense Epb4.l3
and Prelp probes. Images were obtained from the Allen Brain Atlas (http://
www.brain-map.org).
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the course of the 7-day differentiation, with a sharp increase in
bIII-tubulin expression between days 2–5 (Fig. 4C). Interestingly,
whilst both cell types followed the same bIII-tubulin expression
trend, DISP3-expressing cells consistently exhibited a reduced
bIII-tubulin level compared to the control cells (Fig. 4C line graph,
differentiation day 0 is highlighted in bar graph). These data
obtained at the mRNA level were also conﬁrmed morphologically,
when DISP3 cells were unable to form proper neurites and showed
reduced bIII-tubulin immunoﬂuorescence staining after seven days
of culture (note differences in appearance of neurons in control and
DISP3 cells on differentiation day 7 in Fig. 4C).
Glial ﬁbrillary acidic protein (GFAP) is a type-III intermediate
ﬁlament that has previously been used to distinguish astrocytes
[21]. During astrocyte differentiation, GFAP mRNA levels signiﬁ-
cantly increased from undetectable levels at day 0 to relatively
high levels in control cells by day 7 (Fig. 4D). GFAP expression in
DISP3-expressing cells followed a similar pattern to control cells;however, the levels were already reduced by day 3 (Fig. 4D). These
results were corroborated by morphological and immunoﬂuores-
cence studies, which revealed signiﬁcantly reduced GFAP staining
in DISP3-expressing cells at differentiation day 7 (Fig. 4D).
3.5. Disp3 overexpression leads to accumulation of lipids in neural cells
It has previously been shown in ﬁbroblasts that ectopic expres-
sion of DISP3 leads to an increase in the number and size of lipid
droplets and an accumulation of neutral lipids [2]. To evaluate
the lipid content in control and DISP3 C17.2 cells we stained them
with Nile Red, a dye that speciﬁcally associates with neutral lipids.
Fluorescent images show that relative to control cells, DISP3 cells
stain more intensively (Fig. 5A). To quantify these results we ana-
lyzed cells using the high-content analysis. The results shown in
Fig. 5B demonstrate that in comparison to control cells there was
a signiﬁcant increase in Nile Red staining intensity in DISP3 cells,
suggesting these cells contain a higher neutral lipid content
(Fig. 5B).
4. Discussion
In this study we examined the role of DISP3 in the proliferation
and differentiation of the multipotent neural progenitor cell line,
C17.2. These cells were originally established from cerebellar neu-
ral cells isolated from the EGL of neonatal mice [11] and are often
used as an alternative to primary brain tissue cultures, which are a
heterogeneous mixture of cell types [22]. Within the EGL of the
cerebellum there is a transient zone containing granule neuron
precursors (GNPs), which differentiate into granule neurons. It is
widely thought that GNPs whose growth/proliferation is altered
during cerebellar development are at the cellular origin of medul-
loblastoma tumors [23,24].
Ectopic expression of DISP3 in C17.2 cells resulted in prolifera-
tion rates that were 1.7-fold higher than those of control cells.
These results were further conﬁrmed using the human medullo-
blastoma cell line DAOY, suggesting that increased DISP3
expression promotes cellular proliferation.
Gene expression proﬁling of DISP3 C17.2 cells revealed that the
expression of Epb4.1l3 and Prelp mRNA was signiﬁcantly reduced.
Epb4.1l3 is a member of the 4.1 superfamily of proteins that link
transmembrane proteins to the actin cytoskeleton and are fre-
quently lost in brain, lung, breast and prostate cancers [25]. In a
screen for genes involved in prostate cancer metastasis, it was
shown that Epb4.1l3 expression is reduced in highly metastatic
tumors [26]. Moreover, other members of this family have been
shown to enhance the metastatic potential of bone and soft tissue
sarcomas [27], [28]. Prelp was found as a gene that is differentially
expressed in glioblastoma multiforme and meningioma. These two
primary brain tumors are histologically and pathologically distinct
with different prognoses [29], [30]. Prelp is overexpressed in
meningioma together with other members of the small leucine-
rich proteoglycan family [18]. This family of proteins are known
to function in tumor progression; however, their precise role varies
according to the tumor type. Prelp was also identiﬁed in a func-
tional genetic screen initiated to identify genes that allow cells to
bypass cellular senescence [31] and later was additionally
proposed to be involved in the development of accelerated aging
syndrome, Hutchinson-Gilford progeria, [32].
Thus, the downregulation of Epb4.1l3 and Prelp, two genes
directly involved in tumorigenesis, by increased DISP3 expression
in neural cells correlates well with the ability of DISP3 to promote
cell proliferation.
A genome-wide siRNA analysis of p16 modulators in normal
ﬁnite human mammary epithelial cells revealed that Disp3 siRNA
Fig. 4. Ectopic expression of DISP3 in C17.2 cells alters the expression of cell type speciﬁc markers. (A) Multipotent C17.2 neural stem cells give rise to neurons and astrocytes
(oligodendrocytes were not detectable). Cell type speciﬁc markers analyzed were nestin, bIII-tubulin and GFAP. (B) Quantitative RT-PCR analysis of nestin mRNA in control
and DISP3 cells during differentiation days 0–7; Ubb was used as a reference gene. Nestin mRNA levels at day 0 is shown. Immunoﬂuorescent images of cells stained with
nestin (red) and DAPI (blue; to stain nuclei) during differentiation day 0 and 2. (C) Quantitative RT-PCR analysis of bIII-tubulin mRNA in control and DISP3-expressing cells
during differentiation days 0–7; Ubb was used as a reference gene. bIII-tubulin mRNA levels at differentiation day 0 are shown. Bars represent the average of at least three
independent experiments, with error bars representing standard deviation (⁄P < 0.05). Immunoﬂuorescent images of cells stained with bIII-tubulin (red) at differentiation
days 0 and 7. (D) Quantitative RT-PCR analysis of GFAP mRNA in control and DISP3 cells during differentiation days 0–7; Ubb was used as a reference gene.
Immunoﬂuorescent images of cells stained with GFAP (red) at differentiation days 0 and 7. Control (empty vector).
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Fig. 5. Neutral lipid content is enhanced in DISP3-expressing cells. (A) Nile Red
staining (orange) in control and DISP3-expressing cells at differentiation day 0.
DAPI (blue) was used to stain nuclei. (B) The Operetta High-Content Imaging
System was used to quantify the neutral lipid content of control and DISP3-
expressing cells. Bars represent the average of at least three independent exper-
iments with error bars representing standard deviation (⁄P < 0.05). Control (empty
vector).
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expression is low during development, it progressively increases in
a wide variety of tissues during animal aging [34]. p16 acts as a
tumor suppressor by reducing the proliferative capacity of cells,
allowing them to enter senescence. Evidence of the p16 tumor sup-
pressor activity is observed when it is inactivated, leading to the
genesis of a wide spectrum of human cancers [35].
We have demonstrated that ectopic expression of DISP3 alters
the fate of C17.2 neural progenitor cells by promoting cell growth
and inhibiting neural differentiation. Undifferentiated C17.2 cells
express the stem cell marker nestin and the neuronal marker
bIII-tubulin, but little to no expression of the glial marker GFAP
has been detected. In contrast, undifferentiated DISP3-expressing
cells exhibited reduced bIII-tubulin expression, which remained
lower than control cells even after incubation in differentiation
medium. These results suggest that DISP3 overexpression reduces
the ability of C17.2 cells to efﬁciently differentiate. Interestingly,
bIII-tubulin mRNA was signiﬁcantly attenuated not only during
the initial stages of differentiation, but remained consistently
lower than in control cells throughout the 7-day time course.
Whilst GFAP mRNA levels were negligible in both cell types
initially, incubation in differentiation medium resulted in a large
increase in expression. However, GFAP expression was signiﬁ-
cantly attenuated in DISP3-expressing C17.2 cells. Immunoﬂuores-
cence and morphological analysis of these cells during
differentiation conﬁrmed the mRNA expression ﬁndings showing
that DISP3-expressing cells were unable to form neurite out-
growths and exhibited a ﬂat cell shape consistent with undifferen-
tiated cells.
There is a growing body of evidence suggesting the existence of
a link between an altered lipid metabolism and oncogenesis [36].
The increased cellular lipid content may inﬂuence tumor growth
by increasing the pool of building blocks available for membrane
biosynthesis, altering the number of lipid soluble signaling
molecules and enabling the post-translational modiﬁcation ofproteins. Recently it was shown that during cell division the lipi-
dome changes [37]. Nile Red analysis of the lipid content of
C17.2 cells revealed that ectopic expression of DISP3-expressing
cells results in increased cell staining, suggesting that these cells
have a higher neutral lipid content relative to control cells. DISP3
belongs to a class of sterol-sensing domain (SSD) containing
proteins. It is known that SSDs bind sterols and that a mutation
within this domain results in abnormal cholesterol and other lipid
accumulation [38]. Although there is no evidence demonstrating
that DISP3 binds lipids directly, it is known that its overexpression
does increase the cellular lipid content [2]. Our ﬁndings clearly
demonstrate that DISP3 expression alters cell proliferation;
however, we are unable to determine whether this is due to the
altered lipid content or whether the altered lipid content is a
consequence of the increased cell proliferation. Nevertheless,
our study demonstrates that ectopic expression of DISP3 elicits
multiple effects on neural cells, promoting proliferation and
preventing differentiation.
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